UA94478U - A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome - Google Patents

A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome

Info

Publication number
UA94478U
UA94478U UAU201406739U UAU201406739U UA94478U UA 94478 U UA94478 U UA 94478U UA U201406739 U UAU201406739 U UA U201406739U UA U201406739 U UAU201406739 U UA U201406739U UA 94478 U UA94478 U UA 94478U
Authority
UA
Ukraine
Prior art keywords
diagnosing
patients
risk
antiphospholipid syndrome
atherosclerosis
Prior art date
Application number
UAU201406739U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Інна Петрівна Кувікова
Галина Вікторівна Безсмертна
Сергій Вікторович Шевчук
Original Assignee
Науково-Дослідний Інститут Реабілітації Інвалідів (Навчально-Науково-Лікувальний Комплекс) Вінницького Національного Медичного Університету Ім. М.І. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Науково-Дослідний Інститут Реабілітації Інвалідів (Навчально-Науково-Лікувальний Комплекс) Вінницького Національного Медичного Університету Ім. М.І. Пирогова filed Critical Науково-Дослідний Інститут Реабілітації Інвалідів (Навчально-Науково-Лікувальний Комплекс) Вінницького Національного Медичного Університету Ім. М.І. Пирогова
Priority to UAU201406739U priority Critical patent/UA94478U/en
Publication of UA94478U publication Critical patent/UA94478U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for diagnosing the risk of development of atherosclerosis in patients with antiphospholipid syndrome involves determination of the levels of cholesterol, low density lipoproteins, high density lipoproteins, homocysteine, C-reactive protein, IL-6, endothelin-1. At homocysteine levels> 15 mmol / l, C-reactive protein> 5 mg / l, IL-6> 9 ng / ml, endothelin-1> 10 ng / ml atherosclerosis development is predicted.
UAU201406739U 2014-06-16 2014-06-16 A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome UA94478U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201406739U UA94478U (en) 2014-06-16 2014-06-16 A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201406739U UA94478U (en) 2014-06-16 2014-06-16 A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome

Publications (1)

Publication Number Publication Date
UA94478U true UA94478U (en) 2014-11-10

Family

ID=56291861

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201406739U UA94478U (en) 2014-06-16 2014-06-16 A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome

Country Status (1)

Country Link
UA (1) UA94478U (en)

Similar Documents

Publication Publication Date Title
SA518390949B1 (en) Method for determining porosity associated with organic matter in a well or formation
BR112015021281A2 (en) cesium or rubidium secondary ore recovery methods
EP3587596A4 (en) Method for diagnosing chronic obstructive airway disease through bacterial metagenome analysis
EA201690213A1 (en) COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES
IN2014CN04777A (en)
EA201791508A1 (en) TRANSFERENTIAL METHODS AND METHODS OF THEIR USE
WO2014135469A3 (en) Methods for detecting inflammatory disorders
EP3356832A4 (en) Biomarkers and methods for assessing psoriatic arthritis disease activity
MX2023006416A (en) Antibodies, uses & methods.
WO2016012864A3 (en) Biomarkers for anderson-fabry disease
MX2015015015A (en) Method of diagnosing cancer.
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
UA94478U (en) A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome
BR112015023609A2 (en) method and system for transferring user settings to another user receiving device
UA94477U (en) A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome
UA94475U (en) A method for diagnosing the risk of atherosclerosis DEVELOPMENT in patients with antiphospholipid syndrome
FR3028435B1 (en) ASSEMBLY COMPRISING A HOUSING AND A HOOD, AND METHOD FOR ATTACHING THE HOOD TO THE HOUSING
UA94476U (en) A method of diagnosis of atherosclerosis risk of patients with antiphospholipid syndrome
UA89134U (en) Method for diagnosing risk of atherosclerosis in patients with antiphospholipid syndrome
UA95086U (en) METHOD OF DIAGNOSTICS OF THE RISK OF DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH ANTIFOSPHOLIPID SYNDROME
MX2017002453A (en) Neprilysin as heart failure prognostic marker.
UA95085U (en) METHOD OF DIAGNOSIS OF THE DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH ANTIFOSPHOLIPID SYNDROME
UA93330U (en) METHOD for prediction OF FRACTURE nonunion
UA81343U (en) Method for preventing secondary oliguria at early polyuric stage of acute renal failure
Basu et al. Edusearch Bi-lingual Multi-Disciplinary Annual Research Journal